FORGET A BUYOUT!!! ONCE PMCB IS BOUGHT OUT, FOR PROBABLY A LOT LESS THAN IT SHOULD BE, IT'S ALL OVER. IF THEY LICENSE THEIR EXPERTISE TO MULTIPLE BIG PHARMA, IN A VARIETY OF AREAS, THE INCOME STREAM WILL BE GIGANTIC. WITH THE CONTINUING CASH FLOW PMCB CAN CONTINUE TO DO RESEARCH IN MULTIPLE AREAS OF CANCER, DIABETES AND ELSEWHERE AND PROBABLY PAY OUT SOME VERY NICE DIVIDENDS AS WELL!! PRAY FOR A LICENSING AGREEMENT!!
News 
Market Data 
Discover 
